Vaccination for Children of H&O and Their Parents
Study on Compliance, Safety and Effectivity of Vaccination for Children With Hematologic Malignancies or Solid Tumors and Their Parents
Sponsor: Children's Cancer Group, China
This NA trial investigates Hematologic Malignancy and Solid Tumor, Childhood and is currently ongoing. Children's Cancer Group, China leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Nov 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Oct 2021 — Sep 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Mar 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Cancer Group, China
- Shanghai Pudong District Center for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .